LVSD is associated with reduced LV systolic function and geometrical changes.
SUMMARY
Left ventricular failure is strongly associated with secondary mitral valve regurgitation. Implantable soft robotic devices are an emerging technology that enables augmentation of a native function of a target tissue. We demonstrate the ability of a novel soft robotic ventricular assist device to dynamically augment left ventricular contraction, provide native pulsatile flow, simultaneously reshape the mitral valve apparatus, and eliminate the associated regurgitation in an Short-term large animal model of acute left ventricular systolic dysfunction. LHF with reduced ejection fraction is defined as left ventricular systolic dysfunction (LVSD) with an ejection fraction of <40%. The prevalence of LHF with reduced ejection fraction is 6% in symptomatic patients, 5% in asymptomatic patients, and about 3%
in the general population. LVSD is associated with an increased incidence of symptomatic HF and mortality (3, 6, 7) .
In patients with LHF, the shape and function of the LV chamber and the mitral valve (MV) apparatus are closely interrelated (8, 9) . In the majority of patients, the MV is structurally normal, while LV dilatation and an increase in the distance between the LV free wall and interventricular septum (IVS) leads to papillary muscles dislocation, chordae tethering, and loss of leaflet coaptation, which leads to development of secondary MV regurgitation (MVR). Furthermore, LV dilatation leads to MV annulus dilatation and flattening, which contributes to loss of leaflet coaptation height and worsens progression of the LHF (10, 11) . MVR is present in up to 56.2% (mild in 39.4%
and moderate to severe in 16.8%) of patients with LVSD. The coexistence of 2 conditions make the care of this subset of patients more challenging and increase their mortality risk (10, 12, 13) .
Current management strategies address the LHF and secondary MVR separately, even in advanced stages of the LHF (4, 5, 14) . Saeed et al. We dilated the entry point with a 30-F dilator to introduce a left-side disc, which "sandwiched" the IVS, and screwed it with the right-side anchor ( Figure 2G ). At this point, the anchor holder was removed and the brace bar with the cover sleeve introduced through the sheath, was fixed to the leftside disc ( Figure 2H ) and passed through the LV free wall ( Figure 2I ). The entry point was controlled by tightening the purse strings around the cover sleeve and the brace to prevent any bleeding and allow the LV free wall to move freely around the brace. Finally, we fastened the frame with the attached actuators ( Figure 1) to the bar and connected the actuators to the control system.
CONTROL SYSTEM AND DEVICE ACTIVATION. A computer control system was used to operate the SRVAD by inflating and deflating the pneumatic 
RESULTS
The SRVAD operation resulted in geometric changes of the LV chamber and MV apparatus, which translated into functional improvement of LV and MV.
This dynamic support of SRVSD also restored pulsatile blood flow in physiological manner.
We Saeed et al. Figure 3 . In upcoming work, we are planning to test device performance in a chronic LVSD swine model by 
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